Package 16110-247-30

Brand: seysara

Generic: sarecycline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 16110-247-30
Digits Only 1611024730
Product NDC 16110-247
Product ID 16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6
Description

30 TABLET, COATED in 1 BOTTLE (16110-247-30)

Marketing

Marketing Status
Marketed Since 2019-01-04
Brand seysara
Generic sarecycline hydrochloride
Sample Package No

Linked Drug Pages (1)

Seysara ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4f9be4df-4e12-4f08-8e6f-cb07926ea5e6", "openfda": {"upc": ["0316110245300", "0316110246307"], "unii": ["36718856JR"], "rxcui": ["2059023", "2059029", "2059031", "2059033", "2059035", "2059037"], "spl_set_id": ["b200957c-3004-4988-be97-9fd619a83649"], "manufacturer_name": ["Almirall, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE (16110-247-30)", "package_ndc": "16110-247-30", "marketing_start_date": "20190104"}], "brand_name": "Seysara", "product_id": "16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6", "dosage_form": "TABLET, COATED", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Tetracycline-class Drug [EPC]", "Tetracyclines [CS]"], "product_ndc": "16110-247", "generic_name": "sarecycline hydrochloride", "labeler_name": "Almirall, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Seysara", "active_ingredients": [{"name": "SARECYCLINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "NDA209521", "marketing_category": "NDA", "marketing_start_date": "20190104", "listing_expiration_date": "20261231"}